[go: up one dir, main page]

FI974640A7 - Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit - Google Patents

Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit Download PDF

Info

Publication number
FI974640A7
FI974640A7 FI974640A FI974640A FI974640A7 FI 974640 A7 FI974640 A7 FI 974640A7 FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A7 FI974640 A7 FI 974640A7
Authority
FI
Finland
Prior art keywords
isochromans
migraine
disubstituted
treatment
disubstituted isochromans
Prior art date
Application number
FI974640A
Other languages
English (en)
Swedish (sv)
Other versions
FI974640L (fi
FI974640A0 (fi
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI974640A7 publication Critical patent/FI974640A7/fi
Publication of FI974640L publication Critical patent/FI974640L/fi
Publication of FI974640A0 publication Critical patent/FI974640A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI974640A 1995-06-30 1996-06-07 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit FI974640A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (3)

Publication Number Publication Date
FI974640A7 true FI974640A7 (fi) 1997-12-30
FI974640L FI974640L (fi) 1997-12-30
FI974640A0 FI974640A0 (fi) 1997-12-30

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974640A FI974640A0 (fi) 1995-06-30 1996-06-07 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit

Country Status (12)

Country Link
EP (1) EP0836599A1 (fi)
JP (1) JPH11509532A (fi)
AU (1) AU6252296A (fi)
BR (1) BR9609631A (fi)
CA (1) CA2225282A1 (fi)
CZ (1) CZ418597A3 (fi)
FI (1) FI974640A0 (fi)
MX (1) MX9710260A (fi)
NO (1) NO976112L (fi)
PL (1) PL324319A1 (fi)
SK (1) SK164297A3 (fi)
WO (1) WO1997002259A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
JP2007536302A (ja) 2004-05-05 2007-12-13 エフ.ホフマン−ラ ロシュ アーゲー 5−ht6受容体、5−ht2a受容体、又はその両方の調節に有用なアリールスルホニルベンゾジオキサン類
WO2006066746A1 (en) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-ht receptor ligands
ATE409179T1 (de) 2004-12-21 2008-10-15 Hoffmann La Roche Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
HRP20100181T1 (hr) 2004-12-21 2010-05-31 F. Hoffmann - La Roche Ag Derivati tetralina i indana i njihove upotrebe
MX2007007481A (es) 2004-12-21 2007-07-20 Hoffmann La Roche Derivados de tetralina e indano y usos de los mismos.
CA2591810A1 (en) 2004-12-21 2006-06-29 F.Hoffmann-La Roche Ag Chroman derivatives and uses thereof in the treatment of cns disorders
ATE499355T1 (de) 2005-11-03 2011-03-15 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
MX2008015510A (es) 2006-06-20 2008-12-18 Hoffmann La Roche Derivados de arilsulfonamidiltetralina y usos de los mismos.
CN101472884A (zh) 2006-06-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 1,2,3,4-四氢化萘和茚满衍生物及其用途
MX2008015511A (es) 2006-06-20 2008-12-18 Hoffmann La Roche Derivados de arilsulfonilnaftaleno y usos de los mismos.
US20110313197A1 (en) * 2009-03-05 2011-12-22 Sumitomo Chemical Company, Limited Method for producing halogen-substituted benzene dimethanol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
CA2176722A1 (en) * 1993-12-28 1995-07-06 Ruth E. Ten Brink Heterocyclic compounds for the treatment of cns and cardiovascular disorders

Also Published As

Publication number Publication date
MX9710260A (es) 1998-03-29
WO1997002259A1 (en) 1997-01-23
NO976112D0 (no) 1997-12-29
CZ418597A3 (cs) 1998-06-17
NO976112L (no) 1998-03-02
AU6252296A (en) 1997-02-05
SK164297A3 (en) 1998-09-09
JPH11509532A (ja) 1999-08-24
FI974640L (fi) 1997-12-30
EP0836599A1 (en) 1998-04-22
CA2225282A1 (en) 1997-01-23
BR9609631A (pt) 1999-03-02
FI974640A0 (fi) 1997-12-30
PL324319A1 (en) 1998-05-25

Similar Documents

Publication Publication Date Title
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
DE69618634D1 (de) 1,4-benzodioxin-derivate
FI974640L (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
FI20011433L (fi) Menetelmä 2,5,diamino-4,6-diklooripyrimidiinin valmistamiseksi
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
IT1292552B1 (it) Dispositivo per l'applicazione di rivestimenti.
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
EP0811014A4 (en) Novel bacteriocin piscicolin 126
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
FI964278L (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdannaisten valmistamiseksi
FI930237A7 (fi) Menetelmä 4,6-dialkoksipyrimidiinien valmistamiseksi
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid
ES1031096Y (es) Ducha antivandalica.
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
RU95117268A (ru) Средство для лечения атопического дерматита
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ITRM940468A0 (it) "impiego di esteruretani per ls riconcia".